Indication:Local pruritis,neurodermitis,contact dermatitis,seborrheic dermatitis and chronic eczema.

Dosage Form:Cream

Route of Administration:Local Application

Shelf Life:2 years

Storage:Sealed

Package:Aluminum tube

Qualification:Chinese GMP

Indication:1.Skin,finger(toe)infection caused by dermatophyte,yeast and other fungal,such as:tinea corporis,tinea of feet and hands,tinea versicolor,tinea capitis,tinea barbae,tinea unguium,candidiasis of skin a

Dosage Form:Cream

Route of Administration:Local Application

Shelf Life:18 months

Storage:Sealed

Package:Aluminum tube

Qualification:Chinese GMP

Indication:Eczema,contact dermatitis,seborrheic dermatitis,neurodermitis,tinea corporis,tinea cruris and tinea manus and pedis.

Dosage Form:Cream

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Package:Aluminum tube

Qualification:Chinese GMP

Indication:tinea corporis,tinea cruris,tinea manus,tinea pedis,tinea versicolor,tinea capitis,monilial paronychia

Dosage Form:Others

Route of Administration:Local Application

Shelf Life:2 years

Storage:Sealed

Qualification:Chinese GMP

Indication:For the sensitive bacteria-induced skin and soft tissue infections and diseases such as folliculitis,swollen boil,impetigo,traumatism infection and eczema infection

Dosage Form:Others

Route of Administration:Local Application

Shelf Life:2 years

Storage:Sealed

Package:Aluminum tube

Qualification:Chinese GMP

Indication:For inflammatory and allergic nasal congestion, acute and chronic rhinitis

Dosage Form:Drops

Route of Administration:Local Application

Shelf Life:2 years

Storage:Sealed

Qualification:Chinese GMP

Indication:Apply to tympanitis,otitis externa and myringitis due to the sensitive bacteria

Dosage Form:Drops

Route of Administration:Local Application

Shelf Life:2 years

Storage:Sealed

Qualification:Chinese GMP

Specification:100MG 25MG

Dosage Form:Tablet

Active Ingredients:CLOZAPINE

Route of Administration:Oral

Shelf Life:3 years

Storage:Sealed

Package:blister, bottle

Place of Origin:China

Qualification:EU GMP

Indication:Rheumatoid Arthritis (RA) This is an anti-RA drug product for disease control in moderate to severe RA patients. This product can be in combination with methotrexate to reduce signs and symptoms a

Specification:100mg/vial

Dosage Form:Injection

Active Ingredients:infliximab

Route of Administration:Oral

Shelf Life:3 years

Storage:2℃-8℃

Package:vial

Place of Origin:China

Qualification:Chinese GMP

Indication:Approved indications (China) ：Metastatic Colorectal Cancer （mCRC）; Advanced, Recurrent or Metastatic Non– Small Cell Lung Cancer （NSCLC） Indications under Application (China) : Recurrent glioblastom

Specification:100mg/4ml

Dosage Form:Injection

Active Ingredients:bevacizumab

Route of Administration:Oral

Shelf Life:2 years

Storage:2℃-8℃

Package:vial

Place of Origin:China

Qualification:Chinese GMP

Indication:Rheumatoid Arthritis This product can be used in combination with methotrexate, is indicate for: the treatment of moderate to severe, active rheumatoid arthritis in adult patients when the response

Specification:0.8ml, 40mg

Dosage Form:Injection

Active Ingredients:adalimumab

Route of Administration:Intramuscular Injection

Shelf Life:2 years

Storage:2℃-8℃

Package:syringe

Place of Origin:China

Qualification:Chinese GMP

Indication:Indication 1.1 Metastatic Breast Cancer Paclitaxel for Injection is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse with

Specification:100mg

Dosage Form:Injection

Active Ingredients:Paclitaxel

Route of Administration:Subcutaneous Injection

Shelf Life:3 years

Storage:Below 25℃

Package:vial

Place of Origin:China

Qualification:Chinese GMP

Dosage Form:Injection

Route of Administration:Oral

Shelf Life:18 months

Storage:Sealed

Qualification:Chinese GMP

Indication:For the treatment of essential hypertension. For the treatment of patients whose blood pressure cannot be effectively controlled by using irbesartan or hydrochlorothiazide alone.

Specification:150 mg of irbesartan and 12.5 mg of hydrochlorothiazide

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:3 years

Storage:Sealed

Qualification:Chinese GMP

Indication: For the treatment of essential hypertension

Specification:Each tablet contains 20 mg of olmesartan medoxomil and 5 mg of amlodipine besylate

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:Chinese GMP

Indication:For the treatment of hypertension. Indicated in patients whose blood pressure is not adequately controlled with olmesartan medoxomil or hydrochlorothiazide alone.

Specification:Per Tablet Contains: Olmesartan medoxomil 20 mg and Hydrochlorothiazide 12.5 mg

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:Chinese GMP

Indication:Used for adult patients with hypertension whose blood pressure is inadequately controlled by monotherapy. Serves as an alternative therapy for patients with essential hypertension controlled by the c

Specification:Each tablet contains 10 mg of perindopril arginine and 5 mg of amlodipine besylate (calculated as C₂₀H₂₅ClN₂O₅).

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:Chinese GMP

Indication:For the treatment of hypercholesterolemia

Specification:10 mg

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:3 years

Storage:Sealed

Qualification:Chinese GMP

Indication:Treatment of essential hypertension.

Specification:Each tablet contains 80 mg of valsartan and 5 mg of amlodipine.

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:3 years

Storage:Sealed

Qualification:Chinese GMP

Indication: For treating mild to moderate essential hypertension when valsartan alone cannot adequately control blood pressure

Specification:80mg of valsartan potassium and 12.5mg of hydrochlorothiazide

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:Chinese GMP